![Tyson Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Tyson Kim
Sociétés | Poste | Début | Fin |
---|---|---|---|
SYNTEKABIO, INC. | Directeur Général | 01/01/2015 | - |
Radexel Co. Ltd.
![]() Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Directeur Général | - | - |
Historique de carrière de Tyson Kim
Statistiques
Internationale
Etats-Unis | 2 |
Corée du Sud | 2 |
Opérationnelle
Chief Executive Officer | 2 |
Sectorielle
Technology Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SYNTEKABIO, INC. | Technology Services |
Entreprise privées | 1 |
---|---|
Radexel Co. Ltd.
![]() Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Health Technology |